Novel Therapies for Essential Tremor

This study has been completed.

First Received: July 3, 2001 Last Updated: January 20, 2009 History of Changes

Sponsored by:	Department of Veterans Affairs
Information provided by:	Department of Veterans Affairs
ClinicalTrials.gov Identifier:	NCT00018564

Purpose

This clinical research program is designed to evaluate medications as new treatments for essential tremor. Essential tremor is a common condition with few available therapies.

Condition	Intervention	Phase
Essential Tremor	Drug: treatments for essential tremor	Phase III

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Placebo Control, Efficacy Study
Official Title:	Novel Therapies for Essential Tremor

Resource links provided by NLM:

Genetics Home Reference related topics: essential tremor familial paroxysmal nonkinesigenic dyskinesia

MedlinePlus related topics: Tremor

U.S. FDA Resources

Further study details as provided by Department of Veterans Affairs:

Study Start Date:	October 2000
Estimated Study Completion Date:	September 2003

Detailed Description:

Each medication will be evaluated for effectiveness against tremor in a randomized, placebo-controlled, cross-over, double blind clinical research trial.

Tremor will be assessed with accepted rating scales and accelerometry

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Diagnosis of essential tremor.
Tremor rating scale score 3 or one or both upper extremities
Unsatisfactory response to primidone or to propanolol
Not taking tremor-inducing drug
Able to comply with visits

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00018564

Locations

United States, California
VA Greater Los Angeles Healthcare System
Los Angeles, California, United States, 90073

Sponsors and Collaborators

Department of Veterans Affairs

Investigators

Investigator:

Fredricka Martin, Ph.D.

More Information

No publications provided

Study ID Numbers:	NEUD-048-00S
Study First Received:	July 3, 2001
Last Updated:	January 20, 2009
ClinicalTrials.gov Identifier:	NCT00018564 History of Changes
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Signs and Symptoms
Essential Tremor
Movement Disorders
Central Nervous System Diseases

Neurologic Manifestations
Benign Essential Tremor Syndrome
Dyskinesias
Tremor

Additional relevant MeSH terms:

Signs and Symptoms
Essential Tremor
Movement Disorders
Nervous System Diseases

Central Nervous System Diseases
Neurologic Manifestations
Dyskinesias
Tremor

ClinicalTrials.gov processed this record on July 02, 2009